U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675044) titled 'Quantifying the Burden of Type 2 (T2) Inflammation in Asthma' on June 23.
Brief Summary: This study is designed to support the assessment of Type 2 (T2) biomarkers in asthma in primary care and community specialty practices. To assess T2 biomarkers, individuals will be required to complete a breath test for fractional exhaled nitric oxide (FeNO) and consent to a review of their medical records. Asthma often goes undetected in primary care and community settings, and through this study the researchers hope to optimize referral pathways to care.
Study Start Date: July, 2026
Study Type: OBSERVATIONAL
Condition:
Asthma
Type 2 Asthma...